Zydus Cadila gets permission from DCGI for phase-1 clinical trial of novel molecule ZYIL1


PTI, Dec 7, 2020, 12:29 PM IST

New Delhi: Drug firm Zydus Cadila on Monday said it has received permission from Drugs Controller General of India (DCGI) to initiate phase-1 clinical trial of its novel molecule ZYIL1, indicated for use as an inhibitor for inflammation condition ”NLRP3”.

In a regulatory filing, Zydus Cadila said “it has received permission to initiate the phase 1 clinical trial of ZYIL1, a novel oral small molecule NLRP3 inhibitor candidate. NLRP3 inflammasomes are involved in the inflammation process”.

This harmful inflammation within the body leads to the onset and development of various kinds of diseases, including Acute Respiratory Distress Syndrome (ARDS), auto-immune diseases, inflammatory diseases, cardiovascular diseases, metabolic disorders, Gastro-intestinal diseases (inflammatory bowel disease), renal diseases and CNS diseases, the company added.

Pankaj R Patel, Chairman, Cadila Healthcare said: “We will study the safety, tolerability, pharmacokinetics and pharmacodynamics of ZYIL1 in this phase I clinical trial in healthy human volunteers. We are committed to developing these pioneering novel treatments to the clinic for the patients in need.”

Last month, Zydus Cadila had filed the investigational new drug application for ZYIL1, positioned for management of critically ill COVID-19 patients.

Shares of Cadila Healthcare were trading 1.85 per cent higher at Rs 479.70 apiece on BSE.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Sandalwood gains momentum, releases 100 movies in first half of 2022!

US ambassador for religious freedom concerned over the treatment of religious communities in India

Tyres need to meet standards for rolling resistance, wet grip, rolling sound emissions from October

Kaup: Short circuit in school; students rescued

RTO officials warn whiteboard taxi drivers of vehicle seizure

Two hybrid terrorists arrested in Srinagar

Sullia: Minor girl raped, impregnated by relative


Related Articles More

‘Action to be taken against those violating mask rule’

Technical glitch hits compiling of Covid-19 data base for 2nd day

858 COVID-19 cases, 1 death in Karnataka

Mandaviya to chair crucial meeting with experts on rising COVID-19 cases

Karnataka reports 623 COVID-19 cases, 1 death

MUST WATCH

Heavy Rain Mallar Urdu school Damage

Heavy rain at kaup area

Banana cultivation : Success story of a farmer

NEW BULLETIN 30-06-2022

Heavy Rain at Dakshinakannada


Latest Additions

Sandalwood gains momentum, releases 100 movies in first half of 2022!

Akshaya Patra Foundation and NTT Ltd lay foundation stone for govt school in B’luru

Mumbai: Sena MP Sanjay Raut appears before ED

US ambassador for religious freedom concerned over the treatment of religious communities in India

Tyres need to meet standards for rolling resistance, wet grip, rolling sound emissions from October

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.